[1]
A. Hassanzadeh, N. Shomali, A. Kamrani, M. S. Soltani-Zangbar, H. Nasiri, and M. Akbari, “Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs): bench to bedside”, EXCLI J., vol. 23, pp. 862–882, Jun. 2024.